Unresolved issues regarding etiopathogenesis of preeclampsia as a neurogenic neuroimmune phenomenon of the perinatal period

1. Сидорова И.С., Манагадзе И.Д. Современная концепция развития пре­эклампсии: новые данные. Акушерство и гинекология. 2025; 2: 5-13. https://dx.doi.org/10.18565/aig.2024.272 [Sidorova I.S., Managadze I.J. Modern concept of the development of preeclampsia: new data. Obstetrics and Gynecology. 2025; (2): 5-13 (in Russian). https://dx.doi.org/10.18565/aig.2024.272].
2. Kostović I., Sedmak G., Judaš M. Neural histology and neurogenesis of the human fetal and infant brain. Neuroimage. 2019; 188: 743-73. https://dx.doi.org/10.1016/j.neuroimage.2018.12.043
3. Сидорова И.С., Манагадзе И.Д. Современные представления о пре­эклампсии с учетом роли нейронспецифических белков головного мозга плода. Акушерство и гинекология. 2025; 1: 5-11. https://dx.doi.org/10.18565/aig.2024.221 [Sidorova I.S., Managadze I.J. Current understanding of preeclampsia with regard to the role of fetal brain neuron-specific proteins. Obstetrics and Gynecology. 2025; (1): 5-11 (in Russian). https://dx.doi.org/10.18565/aig.2024.221].
4. Kadry H., Noorani B., Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020; 17(1): 69. https://dx.doi.org/10.1186/s12987-020-00230-3
5. Burwick R.M., Feinberg B.B. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Am. J. Obstet. Gynecol. 2022; 226(2S): S1059-70. https://dx.doi.org/10.1016/j.ajog.2020.09.038
6. Collier A.Y., Smith L.A., Karumanchi S.A. Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy. Hum. Immunol. 2021; 82(5): 362-70. https://dx.doi.org/10.1016/j.humimm.2021.01.004
7. Cheng S., Norris W., Kalkunte S., Jash S., Richardson L.R., Sharma S. Evidence for complement activation in preeclampsia placenta and its presence in circulation. Am. J. Reprod. Immunol. 2025; 93(5): e70076. https://dx.doi.org/10.1111/aji.70076
8. Maeda K.J., McClung D.M., Showmaker K.C., Warrington J.P., Ryan M.J., Garrett M.R. et al. Endothelial cell disruption drives increased blood-brain barrier permeability and cerebral edema in the Dahl SS/jr rat model of superimposed preeclampsia. Am. J. Physiol. Heart Circ. Physiol. 2021; 320(2): H535-48. https://dx.doi.org/10.1152/ajpheart.00383.2020
9. Friis T., Wikström A.K., Acurio J., León J., Zetterberg H., Blennow K. et al. Cerebral biomarkers and blood-brain barrier integrity in preeclampsia. Cells. 2022; 11(5): 789. https://dx.doi.org/10.3390/cells11050789
10. Bergman L., Hastie R., Zetterberg H., Blennow K., Schell S., Langenegger E. et al. Evidence of neuroinflammation and blood-brain barrier disruption in women with preeclampsia and eclampsia. Cells. 2021; 10(11): 3045. https://dx.doi.org/10.3390/cells10113045
11. Papapanagiotou A., Daskalaki M.A., Gargalionis A.N., Margoni A., Domali A., Daskalakis G. et al. The role of angiogenetic factors in preeclampsia. Int. J. Mol. Sci. 2025; 26(21): 10431. https://dx.doi.org/10.3390/ijms262110431
12. Burwick R.M., Rodriguez M.H. Angiogenic biomarkers in preeclampsia. Obstet. Gynecol. 2024; 143(4): 515-23. https://dx.doi.org/10.1097/AOG.0000000000005532
13. Escudero C., Kupka E., Ibañez B., Sandoval H., Troncoso F., Wikström A.K. et al. Brain vascular dysfunction in mothers and their children exposed to preeclampsia. Hypertension. 2023; 80(2): 242-56. https://dx.doi.org/10.1161/HYPERTENSIONAHA.122.19408
14. Bergman L., Torres-Vergara P., Penny J., Wikström J., Nelander M., Leon J. et al. Investigating maternal brain alterations in preeclampsia: the need for a multidisciplinary effort. Curr. Hypertens Rep. 2019; 21(9): 72. https://dx.doi.org/10.1007/s11906-019-0977-0
15. Canjels L.P.W., Jansen J.F.A., Alers R.J., Ghossein-Doha C., van den Kerkhof M., Schiffer V.M.M.M. et al. Blood-brain barrier leakage years after pre-eclampsia: dynamic contrast-enhanced 7-Tesla MRI study. Ultrasound Obstet. Gynecol. 2022; 60(4): 541-8. https://dx.doi.org/10.1002/uog.24930
16. Mahendra V., Clark S.L., Suresh M.S. Neuropathophysiology of preeclampsia and eclampsia: a review of cerebral hemodynamic principles in hypertensive disorders of pregnancy. Pregnancy Hypertens. 2021; 23(3): 104-11. https://dx.doi.org/10.1016/j.preghy.2020.10.013
17. Li J., Zheng M., Shimoni O., Banks W.A., Bush A.I., Gamble J.R. et al. Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier. Adv. Sci. (Weinh). 2021; 8(16): 2101090. https://dx.doi.org/10.1002/advs.202101090
18. Li W., Pan R., Qi Z., Liu K.J. Current progress in searching for clinically useful biomarkers of blood-brain barrier damage following cerebral ischemia. Brain Circ. 2018; 4(4): 145-52. https://dx.doi.org/10.4103/bc.bc_11_18
19. Misan N., Michalak S., Rzymski P., Poniedziałek B., Kapska K., Osztynowicz K. et al. Molecular indicators of blood-brain barrier breakdown and neuronal injury in pregnancy complicated by fetal growth restriction. Int. J. Mol. Sci. 2022; 23(22): 13798. https://dx.doi.org/10.3390/ijms232213798
20. Zhang Y., Zhao H.J., Xia X.R., Diao F.Y., Ma X., Wang J. et al. Hypoxia-induced and HIF1α-VEGF-mediated tight junction dysfunction in choriocarcinoma cells: Implications for preeclampsia. Clin. Chim. Acta. 2019; 489: 203-11. https://dx.doi.org/10.1016/j.cca.2017.12.010
21. Miller E.C. Preeclampsia and cerebrovascular disease: the maternal brain at risk. Hypertension. 2019; 74(1): 5­13. https://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11513
22. Szyndler A., Adamski P., Kowalczyk K., Gąsecki D. Cerebrovascular disease in preeclampsia. In: Coca A., ed. Hypertension and brain damage. Updates in hypertension and cardiovascular protection. Cham: Springer; 2024: 253-72. https://dx.doi.org/10.1007/978-3-031-64928-8_17
23. Bergman L., Hannsberger D., Schell S., Imberg H., Langenegger E., Moodley A. et al. Cerebral infarcts, edema, hypoperfusion, and vasospasm in preeclampsia and eclampsia. Am. J. Obstet. Gynecol. 2025; 232(6): 550.e1-14. https://dx.doi.org/10.1016/j.ajog.2024.10.034
24. Gumusoglu S.B., Chilukuri A.S.S., Santillan D.A., Santillan M.K., Stevens H.E. Neurodevelopmental outcomes of prenatal preeclampsia exposure. Trends Neurosci. 2020; 43(4): 253-68. https://dx.doi.org/10.1016/j.tins.2020.02.003
25. González-Rojas A., Valencia-Narbona M. Neurodevelopmental disruptions in children of preeclamptic mothers: pathophysiological mechanisms and consequences. Int. J. Mol. Sci. 2024; 25(7): 3632. https://dx.doi.org/10.3390/ijms25073632
26. Staud F., Karahoda R. Trophoblast: the central unit of fetal growth, protection and programming. Int. J. Biochem. Cell. Biol. 2018; 105: 35­40. https://dx.doi.org/10.1016/j.biocel.2018.09.016
27. Kratimenos P., Penn A.A. Placental programming of neuropsychiatric disease. Pediatr. Res. 2019; 86(2): 157­64. https://dx.doi.org/10.1038/ s41390­019­0405­9
28. Creeth H.D.J., John R.M. The placental programming hypothesis: Placental endocrine insufficiency and the co­occurrence of low birth weight and maternal mood disorders. Placenta. 2020; 98: 52­9. https://dx.doi.org/10.1016/j.placenta.2020.03.011
29. Ortega M.A., Fraile-Martínez O., García-Montero C., Sáez M.A., Álvarez-Mon M.A., Torres-Carranza D. et al. The pivotal role of the placenta in normal and pathological pregnancies: a focus on preeclampsia, fetal growth restriction, and maternal chronic venous disease. Cells. 2022; 11(3): 568. https://dx.doi.org/10.3390/cells11030568
30. Scott H., Phillips T.J., Stuart G.C., Rogers M.F., Steinkraus B.R., Grant S. et al. Preeclamptic placentae release factors that damage neurons: implications for foetal programming of disease. Neuronal Signal. 2018; 2(4): NS20180139. https://dx.doi.org/10.1042/NS20180139
31. Gumusoglu S.B. The role of the placenta-brain axis in psychoneuroimmune programming. Brain Behav. Immun. Health. 2024; 36: 100735. https://dx.doi.org/10.1016/j.bbih.2024.100735
32. Liu D., Gao Q., Wang Y., Xiong T. Placental dysfunction: The core mechanism for poor neurodevelopmental outcomes in the offspring of preeclampsia pregnancies. Placenta. 2022; 126(3): 224-32. https://dx.doi.org/10.1016/j.placenta.2022.07.014
33. Shallie P.D., Naicker T. The placenta as a window to the brain: A review on the role of placental markers in prenatal programming of neurodevelopment. Int. J. Dev. Neurosci. 2019; 73(1): 41-9. https://dx.doi.org/10.1016/j.ijdevneu.2019.01.003
34. Rosenfeld C.S. The placenta-brain-axis. J. Neurosci. Res. 2021; 99(1): 271-83. https://dx.doi.org/10.1002/jnr.24603
35. Gardella B., Dominoni M., Scatigno A.L., Cesari S., Fiandrino G., Orcesi S. et al. What is known about neuroplacentology in fetal growth restriction and in preterm infants: a narrative review of literature. Front. Endocrinol. (Lausanne). 2022; 13: 936171. https://dx.doi.org/10.3389/fendo.2022.936171
36. Сидорова И.С., Манагадзе И.Д. Сущность преэклампсии и возможности ее прекращения. Акушерство и гинекология. 2026; 1: 5-11. https://dx.doi.org/10.18565/aig.2025.223 [Sidorova I.S., Managadze I.J. The essence of preeclampsia and the possibility of its termination. Obstetrics and Gynecology. 2026; (1): 5-11 (in Russian). https://dx.doi.org/10.18565/aig.2025.223].
37. Vinci L. Immunohistochemical markers of stem/progenitor cells in the developing human cerebral cortex. 2017.
38. Nogueira-Vale E. Brain development. In: Oxytocin, well-being and affect regulation. Springer, Cham; 2024: 64-74. https://dx.doi.org/10.1007/978-3-031-59038-2_6
39. Цехмистренко Т.А., Васильева В.А., Обухов Д.К., Шумейко Н.С. Строение и развитие коры большого мозга. М.: Спутник+; 2019. 538 с. [Tsekhmistrenko T.A., Vasilyeva V.A., Obukhov D.K., Shumeiko N.S. Structure and development of the cerebral cortex. Moscow: Sputnik+; 2019. 538 p. (in Russian)].
40. Циркин В.И., Трухина С.И., Трухин А.Н. Нейрофизиология: основы нейрофизиологии. Учебник для вузов. 2-е изд., испр. и доп. М.: Юрайт; 2023. 504 c. [Tsirkin V.I., Trukhina S.I., Trukhin A.N. Neurophysiology: basis of neurophysiology. Textbook for universities. 2nd ed., rev. exp. Moscow: Yurayt; 2023. 504 p. (in Russian)].
41. Salihagić A., Kurjak A. Cognitive functions of the fetus. Kognitive funktionen beim feten. Ultraschall in der Medizin. 2018; 39(2), 181-9. https://dx.doi.org/10.1055/s-0043-123469
42. Fagard J., Esseily R., Jacquey L., O'Regan K., Somogyi E. Fetal origin of sensorimotor behavior. Front. Neurorobot. 2018; 12: 23. https://dx.doi.org/10.3389/fnbot.2018.00023
43. Mariani B., Nicoletti G., Barzon G., Ortiz Barajas M.C., Shukla M., Guevara R. et al. Prenatal experience with language shapes the brain. Sci. Adv. 2023; 9(47): eadj3524. https://dx.doi.org/10.1126/sciadv.adj3524
44. Moser J., Schleger F., Weiss M., Sippel K., Semeia L., Preissl H. Magnetoencephalographic signatures of conscious processing before birth. Dev. Cogn. Neurosci. 2021; 49: 100964. https://dx.doi.org/10.1016/j.dcn.2021.100964
45. Falsaperla R., Collotta A.D., Spatuzza M., Familiari M., Vitaliti G., Ruggieri M. Evidences of emerging pain consciousness during prenatal development: a narrative review. Neurol. Sci. 2022; 43(6): 3523-32. https://dx.doi.org/10.1007/s10072-022-05968-2
46. Chorna O., Filippa M., De Almeida J.S., Lordier L., Monaci M.G., Hüppi P. et al. Neuroprocessing mechanisms of music during fetal and neonatal development: a role in neuroplasticity and neurodevelopment. Neural Plast. 2019; 2019: 3972918. https://dx.doi.org/10.1155/2019/3972918
47. Bayne T., Frohlich J., Cusack R., Moser J., Naci L. Consciousness in the cradle: on the emergence of infant experience. Trends Cogn. Sci. 2023; 27(12): 1135-49. https://dx.doi.org/10.1016/j.tics.2023.08.018
48. Kumar N., Kamath S., Kumar G., Kh V., Kumar Sinha M., Amin R. et al. Prenatal learning and memory: review on the impact of exposure. Curr. Pediatr. Rev. 2023; 19(2): 108-20. https://dx.doi.org/10.2174/1573396318666220601160537
49. Yuan X., Li W., Yan Q., Ou Y., Long Q., Zhang P. Biomarkers of mature neuronal differentiation and related diseases. Future Sci. OA. 2024; 10(1): 2410146. https://dx.doi.org/10.1080/20565623.2024.2410146
50. Bergman L., Zetterberg H., Kaihola H., Hagberg H., Blennow K., Åkerud H. Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study. PLoS One. 2018; 13(5): e0196025. https://dx.doi.org/10.1371/journal.pone.0196025
51. Bergman L., Hastie R., Bokström-Rees E., Zetterberg H., Blennow K., Schell S. et al. Cerebral biomarkers in neurologic complications of preeclampsia. Am. J. Obstet. Gynecol. 2022; 227(2): 298.e1-10. https://dx.doi.org/10.1016/j.ajog.2022.02.036
52. Liao J., Zhang Z., Huang W., Huang Q., Bi G. Neonatal neuron specific enolase, a sensitive biochemical marker of neuronal damage, is increased in preeclampsia: A retrospective cohort study. Brain Dev. 2020; 42(8): 564-71. https://dx.doi.org/10.1016/j.braindev.2020.04.011
53. Busse M., Scharm M., Oettel A., Redlich A., Costa S.D., Zenclussen A.C. Enhanced S100B expression in T and B lymphocytes in spontaneous preterm birth and preeclampsia. J. Perinat. Med. 2021; 50(2): 157-66. https://dx.doi.org/10.1515/jpm-2021-0326
54. Karampas G., Tzelepis A., Koulouraki S., Lykou D., Metallinou D., Erlandsson L. et al. The utility of maternal blood S100B in women with suspected or established preeclampsia – a systematic review. Biomolecules. 2025; 15(6): 840. https://dx.doi.org/10.3390/biom15060840
55. Wu J., Sheng X., Zhou S., Fang C., Song Y., Wang H. et al. Clinical significance of S100B protein in pregnant woman with early- onset severe preeclampsia. Ginekol. Pol. 2024; 95(9): 711-7. https://dx.doi.org/10.5603/GP.a2021.0126
56. Lederer W., Dominguez C.A., Popovscaia M., Putz G., Humpel C. Cerebrospinal fluid levels of tau and phospho-tau-181 proteins during pregnancy. Pregnancy Hypertens. 2016; 6(4): 384-7. https://dx.doi.org/10.1016/j.preghy.2016.08.243
57. Wang Y., Guo B., Zhao K., Yang L., Chen T. Correlation between cognitive impairment and serum phosphorylated tau181 protein in patients with preeclampsia. Front. Aging Neurosci. 2023; 15: 1148518. https://dx.doi.org/10.3389/fnagi.2023.1148518
58. Jash S., Banerjee S., Cheng S., Wang B., Qiu C., Kondo A. et al. Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia. Nat. Commun. 2023; 14(1): 5414. https://dx.doi.org/10.1038/s41467-023-41144-6
59. Andersson M., Oras J., Thörn S.E., Karlsson O., Kälebo P., Zetterberg H. et al. Signs of neuroaxonal injury in preeclampsia – a case control study. PLoS One. 2021; 16(2): e0246786. https://dx.doi.org/10.1371/journal.pone.0246786
60. Gu X., Rana S., Ngo L., Mueller A., Dillon S., Salahuddin et al. Plasma markers of neurological injury are elevated in preeclampsia. Pregnancy Hypertension. 2025; 42: 101265. https://dx.doi.org/10.1016/j.preghy.2025.101265
61. Goasdoué K., Miller S.M., Colditz P.B., Björkman S.T. Review: the blood-brain barrier; protecting the developing fetal brain. Placenta. 2016; 54: 111-6. https://dx.doi.org/10.1016/j.placenta.2016.12.005
62. Сидорова И.С., Никитина Н.А. Обоснование современной концепции развития преэклампсии. Акушерство и гинекология. 2019; 4: 26-33. https://dx.doi.org/10.18565/aig.2019.4.26-33 [Sidorova I.S., Nikitina N.A. Validation of the modern concept of the development of preeclampsia. Obstetrics and Gynecology. 2019; (4): 26-33 (in Russian). https://dx.doi.org/10.18565/aig.2019.4.26-33].
63. Сидорова И.С., Никитина Н.А. Течение и ведение беременности по триместрам ее развития. Руководство. М.: ГЭОТАР-Медиа; 2021. 584 с. [Sidorova I.S., Nikitina N.A. Course and management of pregnancy by trimesters of its development. Guide. Moscow: GEOTAR-Media; 2021. 584 p. (in Russian)].
64. Kadry H., Noorani B., Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020; 17(1): 69. https://dx.doi.org/10.1186/s12987-020-00230-3
65. Wang J., Xu F., Zhu X., Li X., Li Y., Li J. Targeting microRNAs to Regulate the Integrity of the Blood-Brain Barrier. Front. Bioeng. Biotechnol. 2021; 9: 673415. https://dx.doi.org/10.3389/fbioe.2021.673415
66. Toyama K., Spin J.M., Deng A.C., Huang T.T., Wei K., Wagenhäuser M.U. et al. MicroRNA-mediated therapy modulating blood-brain barrier disruption improves vascular cognitive impairment. Arterioscler. Thromb. Vasc. Biol. 2018; 38(6): 1392-406. https://dx.doi.org/10.1161/ATVBAHA.118.310822
67. Congdon E.E., Ji C., Tetlow A.M., Jiang Y., Sigurdsson E.M. Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat. Rev. Neurol. 2023; 19(12): 715-36. https://dx.doi.org/10.1038/s41582-023-00883-2
68. Sarkar S., Porel P., Kosey S., Aran K.R. Diverse role of S100 calcium-binding protein B in alzheimer's disease: pathological mechanisms and therapeutic implications. Inflammopharmacology. 2025; 33(4): 1803-16. https://dx.doi.org/10.1007/s10787-025-01697-y
69. Kocurova G., Ricny J., Ovsepian S.V. Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases. Theranostics. 2022; 12(7): 3045-56. https://dx.doi.org/10.7150/thno.72126
70. Torres-Vergara P., Troncoso F., Acurio J., Kupka E., Bergman L., Wikström A.K. et al. Dysregulation of vascular endothelial growth factor receptor 2 phosphorylation is associated with disruption of the blood-brain barrier and brain endothelial cell apoptosis induced by plasma from women with preeclampsia. Biochim. Biophys. Acta Mol. Basis Dis. 2022; 1868(9): 166451. https://dx.doi.org/10.1016/j.bbadis.2022.166451
71. Mukherjee I., Singh S., Karmakar A., Kashyap N., Mridha A.R., Sharma J.B. et al. New immune horizons in therapeutics and diagnostic approaches to Preeclampsia. Am. J. Reprod. Immunol. 2023; 89(2): e13670. https://dx.doi.org/10.1111/aji.13670

Received 24.11.2025

Accepted 02.06.2026